ϟ
DOI: 10.1038/nrc2664
OpenAccess: Closed
This work is not Open Acccess. We may still have a PDF, if this is the case there will be a green box below.
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
PI3K/AKT/mTOR pathway
Signalling pathways
Cancer
2009
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“Targeting PI3K signalling in cancer: opportunities, challenges and limitations” is a paper by Jeffrey A. Engelman published in 2009. It has an Open Access status of “closed”. You can read and download a PDF Full Text of this paper here.